Cargando…
(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient
INTRODUCTION: Guillain-Barré Syndrome (GBS) is an immune-mediated neurological disorder with an estimated incidence of 1 to 2 per 100,000 person-years. GBS is characterized by progressive and symmetric ascending muscle weakness, areflexia, sensory symptoms, and dysautonomia. Antecedent infection or...
Autores principales: | Sindu, D., Arjuna, A., Mcannally, K., Buddhdev, B., Walia, R., Mohamed, H., Abdelrazek, H., Omar, A., Tokman, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068073/ http://dx.doi.org/10.1016/j.healun.2023.02.1408 |
Ejemplares similares
-
mRNA-1273: Guillain-Barre syndrome: case report
Publicado: (2021) -
PROLONGED COLONIZATION AND COISOLATION OF SARS-COV-2 IN UNVACCINATED RECIPIENTS OF LUNG TRANSPLANTS
por: RAZIA, DEEPIKA, et al.
Publicado: (2022) -
Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2021) -
(349) Molnupiravir vs Remdesivir for Treatment of Covid-19 in Lung Transplant Recipients
por: Razia, D., et al.
Publicado: (2023) -
Sub-acute Onset of Guillain-Barré Syndrome Post-mRNA-1273 Vaccination: a Case Report
por: Nagalli, Shivaraj, et al.
Publicado: (2022)